Skip to main content

What the FDA labels say about taking them together

Aprepitant and drospirenone

Drospirenone's FDA label of August 27, 2026 names aprepitant in its drug interactions section; the aprepitant labels PlainMeds reads (3) do not name drospirenone. The drospirenone label: “… felbamate, griseofulvin, oxcarbazepine, rifampicin, rifabutin, rufinamide, aprepitant, and products containing St. John's wort.”

Check it at the source: the aprepitant FDA label on DailyMed (effective July 5, 2024, Merck Sharp & Dohme LLC); the drospirenone FDA label on DailyMed (effective August 27, 2026, Exeltis USA, Inc.).

What does the aprepitant label say about drospirenone?

Aprepitant's label (effective July 5, 2024) and its 2 other brand-application labels do not name drospirenone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (EMEND), NDA021549 (Msd), as published by Merck Sharp & Dohme LLC, effective July 5, 2024 (SPL set 696f9e80-9cae-403b-de9e-078343ce4713), via openFDA; the full label on DailyMed

What does the drospirenone label say about aprepitant?

Drospirenone label, drug interactions

Some drugs or herbal products that may decrease the effectiveness of HCs include efavirenz, phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, rifabutin, rufinamide, aprepitant, and products containing St. John's wort.

Source: FDA drug label (SLYND), Exeltis USA, Inc., effective August 27, 2026 (SPL set db32bc55-f295-4d87-9dbb-0a2f45573dcf), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Aprepitant generic labelers
0Drospirenone generic labelers
AprepitantDrospirenone
Labeled forNausea and vomitingBirth control
Boxed warningNoNo
Pharmacy cost (NADAC)$46.42 per capsule 40 mg capsule$6.61 per tablet 4 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?